Dr. Bloch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
NYP- Columbia University Medical Center, Department of Radiology
New York, NY 10032- Is this information wrong?
Summary
- As a radiologist at an academic medical center, I am devoted to improving clinical care for my patients suffering from breast and prostate cancer. My research has focused on developing new imaging protocols and on correlating prostate and breast cancer imaging phenotypes and MR/US imaging classifiers with histology, immunohistochemistry, and gene expression profiles. I recognize the imperative need for correlating imaging phenotypes with tumor genotypes in order to advance knowledge regarding a broad range of breast and prostate diseases, as well as their early diagnosis, progression/behavior and treatment, by developing new (imaging) biomarkers.
A second major research focus is the design and development of biopsy and treatment tools, like biopsy markers (biopsy clips; Coulter Translational Research Award BU 2011), and treatment planning phantoms and atlases in collaboration with biomedical and computational engineers and image post-processors.
Education & Training
- Brigham and Women's Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Women's Imaging, 2008 - 2009
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Body Imaging/Cross Sectional Imaging/MRI, 2003 - 2006
- General Hospital Vienna – Medical University Vienna, AustriaDiagnostic Radiology, 1999 - 2003
- Sourasky Medical Center Tel Aviv UniversityHouse Officer, 1998 - 1999
- University of Vienna Faculty of MedicineClass of 1997, MD; Dr. med. Univ.
Certifications & Licensure
- MA State Medical License 2003 - Present
Awards, Honors, & Recognition
- Coulter Award 2011
Clinical Trials
- Dotarem vs Gadobutrol Contrast for Breast MRI Start of enrollment: 2021 Mar 01
Publications & Presentations
PubMed
- 23 citationsMultisite evaluation of radiomic feature reproducibility and discriminability for identifying peripheral zone prostate tumors on MRI.Prathyush Chirra, Patrick Leo, Michael Yim, B. Nicolas Bloch, Ardeshir R. Rastinehad, Andrei S. Purysko, Mark A. Rosen, Anant Madabhushi, Satish Viswanath> ;Journal of Medical Imaging. 2019 Apr 1
- Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, Bates DDB, Gallagher K, Bloch BN, Vulchi M, Turk P, Bera K, Abraham J, Sikov WM, Somlo G, Harris LN, Gilmo...> ;JAMA network open. 2019-04-05
- Comparing radiomic classifiers and classifier ensembles for detection of peripheral zone prostate tumors on T2-weighted MRI: a multi-site study.Viswanath SE, Chirra PV, Yim MC, Rofsky NM, Purysko AS, Rosen MA, Bloch BN, Madabhushi A> ;BMC medical imaging. 2019-02-28
- Join now to see all
Other Languages
- German, Hebrew
Hospital Affiliations
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: